Search results
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...
Rome Sentinel· 2 days agoPositive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to standard of care and significant reduction ...
Ultrasound technology is used in many ways — addiction is the next frontier | Texarkana Gazette
Texarkana Gazette· 5 days agoNestled inside a giant MRI machine, the woman wears a helmet outfitted with special probes. Beams of...
Raymond James Cuts HLS Therapeutics (TSE:HLS) Price Target to C$4.00
ETF DAILY NEWS· 4 days agoHLS Therapeutics (TSE:HLS – Free Report) had its target price cut by Raymond James from C$5.00 to C$4.00 in a report issued on Friday morning, BayStreet.CA reports. A number of other research ...